跳至主要内容
临床试验/NCT03093987
NCT03093987已完成不适用

Critical Care Ultrasound Oriented Shock Treatment in ICU

West China Hospital1 个研究点 分布在 1 个国家目标入组 150 人开始时间: 2017年4月5日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
150
试验地点
1
主要终点
28-day mortality

研究概览

简要总结

Objective

To investigate whether critical care ultrasound oriented shock management in shock patients in intensive care unit(ICU) can improve outcome.

Methods

Randomized controlled research. Patients were randomly allocated to two groups. In the critical care ultrasound oriented shock management group (CUSS group), treatment was oriented by the findings of critical care ultrasound in each shock phase, while in the control group the decisions about the monitoring and management were made by the clinical team. The goal of treatments in both groups were decreasing lactate by 20% or more per 2 hours for the Optimization phase in shock management, and no increase lactate level when removing the fluid in de-escalation phase. The primary outcome measure were hospital mortality and 28-day mortality, the secondary outcome measure were the length of ventilation and the length of ICU stay.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Participant)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • SBP <90 mm Hg or MAP <65 mm Hg or SBP decrease >40mmHg or need vasoactive drugs;
  • Skin that is cold and clammy,capillary refill time >4.5s,urine output of<0.5ml/Kg.hr and lactate >2mmol/L;
  • SHOCK presented within 6 hr.

排除标准

  • <18 years old;
  • Pregnancy;
  • Patient or family member refuse to be enrolled.

研究组 & 干预措施

control group

No Intervention

usual care

critical care ultrasound

Experimental

Circulation management will be adjusted according to the results of critical ultrasound combined with clearance of lactic acid in patients with shock.

干预措施: Critical care ultrasound (Other)

结局指标

主要结局

28-day mortality

时间窗: through study completion,an average of 28 days

28-day mortality

次要结局

  • the incidence of AKI(through study completion,an average of 28 days)
  • the total length of hospital stay(through study completion,an average of 28 days)
  • the length of ICU stay(through study completion,an average of 28 days)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

tongjuan ZOU

Professor

West China Hospital

研究点 (1)

Loading locations...

相似试验